At these symposia, we will demonstrate how High Throughput SPR has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step.
Cambridge, MA September 10, 2019 |
San Diego, CA September 17, 2019 |
San Francisco, CA September 19, 2019 |
Munich, Germany October 08, 2019 |